Pharma News

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

- Read more about Baxalta Singapore facility receives FDA approval in providing reliable supply to hemophilia patients
Baxalta Incorporated, a global biopharmaceutical leader dedicated to delivering transformative therapies to patients with orphan diseases and underserved conditions, announced today that its state-of-the-art recombinant biologic manufacturing facility in Singapore received U.S. Food and Drug Administration (FDA) approval to produce ADVATE [Antihemophilic Factor (Recombinant)] bulk drug substance (BDS). The site received regulatory approval from the European Medicines Agency in January 2014 for the production of ADVATE.
- Read more about NeuroSigma's Monarch eTNS System to treat ADHD receives CE Mark approval
NeuroSigma, Inc. (NeuroSigma), a California-based life sciences company, announced that it has received CE Mark approval for its Monarch eTNS System as treatment for attention-deficit/hyperactivity disorder (ADHD) in adults and children age 7 and older. This CE Mark approval is the first for any non-drug treatment of ADHD in the European Union (EU).
- Read more about Gilead present 32 scientific presentations for investigational HCV therapies at The Liver Meeting 2015
Gilead Sciences, Inc. announced it will present 32 scientific presentations related to its approved medicines and investigational therapies for the treatment of chronic hepatitis C virus (HCV) infection at The Liver Meeting 2015 in San Francisco.
- Read more about FDA grant accelerated approval for Darzalex for patients with previously treated multiple myeloma
U.S. Food and Drug Administration granted accelerated approval for Darzalex (daratumumab) to treat patients with multiple myeloma who have received at least three prior treatments. Darzalex is the first monoclonal antibody approved for treating multiple myeloma. Darzalex is marketed by Janssen Biotech of Horsham, Pennsylvania.
- Read more about Coherus, Baxalta announce CHS-0214 meets primary endpoint in phase 3 psoriasis study
Coherus BioSciences and Baxalta has recently announced that CHS-0214, a proposed biosimilar of Enbrel (etanercept), met its primary endpoints in a confirmatory, double-blind, randomized, controlled, two-part phase 3 study. This on-going 52-week study is evaluating the efficacy and safety of CHS-0214 compared to Enbrel in patients with moderate-to-severe chronic plaque psoriasis. Coherus and Baxalta initiated a collaboration to develop and commercialise CHS-0214 in September of 2013.
- Read more about TCS delivers SAP Transformation for Australian Pharmaceutical Industries
Tata Consultancy Services, a leading IT services, consulting and business solutions firm, today announced the go-live of a comprehensive IT and business transformation program for Australian Pharmaceutical Industries (API), a leading Australian health and beauty company.

[adsense:336x280:8701650588]
- Read more about Child with drug-resistant TB treated successfully in US
A team of specialists at Johns Hopkins Children's Centre, including one of Indian origin, has successfully treated a child with a highly virulent form of tuberculosis known as XDR TB, or extensively drug-resistant TB.
- Read more about Inexpensive one-step test for hepatitis C infection
Researchers have developed a cost-effective one-step test that can screen, detect and confirm hepatitis C virus (HCV) infections from blood or urine samples. Current blood-based HCV testing requires two steps and can be expensive, inconvenient and is not widely available or affordable globally.
- Read more about Pharmacy selling cancer drugs at heavy discount opened
Union Health Minister J.P. Nadda on Sunday inaugurated India's first retail facility at AIIMS to provide drugs for cancer and cardiovascular diseases at highly discounted rates.
- Read more about Lead exposure hampers children's sleep quality
Lead exposure in early in life is associated with increased risk of sleep problems and excessive daytime sleepiness in later childhood, says a new study.